International audienceWe demonstrate an accurate and sensitive quantification of mutated KRAS oncogene in genomic DNA, using droplet-based microfluidics and digital PCR
Constitutively active KRAS mutations have been found to be involved in various processes of cancer d...
Circulating tumor DNA (ctDNA) is released from cancer cells and oncogenic mutations in ctDNA can be ...
<div><p>Droplet digital PCR (ddPCR) can be used to detect low frequency mutations in oncogene-driven...
International audienceWe demonstrate an accurate and sensitive quantification of mutated KRAS oncoge...
International audienceWe describe a droplet microfluidics method to screen for multiple mutations of...
International audienceSomatic mutations within tumoral DNA can be used as highly specific biomarkers...
The KRAS oncogene is involved in the pathogenesis of several types of cancer, particularly colorecta...
Droplet digital PCR (ddPCR) can be used to detect low frequency mutations in oncogene-driven lung ca...
cogene homolog) alleles may provide information in addition to that provided by standard mutation-de...
© 2015 Pender et al. This is an open access article distributed under the terms of the Creative Comm...
Pancreatic cancer is a terminal disease with high mortality and very poor prognosis. A sensitive and...
The aim of this work is to establish novel strategies for the highly sensitive screening of cancer b...
Constitutively active KRAS mutations have been found to be involved in various processes of cancer d...
International audienceThe efficient characterization of genetic and epigenetic alterations in oncolo...
Measuring total cell-free DNA (cfDNA) or cancer-specific mutations herein has presented as new tools...
Constitutively active KRAS mutations have been found to be involved in various processes of cancer d...
Circulating tumor DNA (ctDNA) is released from cancer cells and oncogenic mutations in ctDNA can be ...
<div><p>Droplet digital PCR (ddPCR) can be used to detect low frequency mutations in oncogene-driven...
International audienceWe demonstrate an accurate and sensitive quantification of mutated KRAS oncoge...
International audienceWe describe a droplet microfluidics method to screen for multiple mutations of...
International audienceSomatic mutations within tumoral DNA can be used as highly specific biomarkers...
The KRAS oncogene is involved in the pathogenesis of several types of cancer, particularly colorecta...
Droplet digital PCR (ddPCR) can be used to detect low frequency mutations in oncogene-driven lung ca...
cogene homolog) alleles may provide information in addition to that provided by standard mutation-de...
© 2015 Pender et al. This is an open access article distributed under the terms of the Creative Comm...
Pancreatic cancer is a terminal disease with high mortality and very poor prognosis. A sensitive and...
The aim of this work is to establish novel strategies for the highly sensitive screening of cancer b...
Constitutively active KRAS mutations have been found to be involved in various processes of cancer d...
International audienceThe efficient characterization of genetic and epigenetic alterations in oncolo...
Measuring total cell-free DNA (cfDNA) or cancer-specific mutations herein has presented as new tools...
Constitutively active KRAS mutations have been found to be involved in various processes of cancer d...
Circulating tumor DNA (ctDNA) is released from cancer cells and oncogenic mutations in ctDNA can be ...
<div><p>Droplet digital PCR (ddPCR) can be used to detect low frequency mutations in oncogene-driven...
DOI
Add to ORKG